SS
MRNA icon

Simplicity Solutions’s Moderna MRNA Stock Holding History

Simplicity Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$333K Sell
3,349
-1,062
-24% -$89.3K 0.01% 801
2023
Q3 		$456K Buy
4,411
+497
+13% +$55.4K 0.01% 628
2023
Q2 		$476K Sell
3,914
-4,129
-51% -$551K 0.01% 679
2023
Q1 		$1.24M Buy
8,043
+5,030
+167% +$830K 0.03% 422
2022
Q4 		$541K Buy
3,013
+436
+17% +$71.3K 0.07% 320
2022
Q3 		$305K Buy
2,577
+216
+9% +$32.8K 0.04% 456
2022
Q2 		$337K Sell
2,361
-440
-16% -$62.9K 0.04% 401
2022
Q1 		$483K Sell
2,801
-1,585
-36% -$267K 0.06% 313
2021
Q4 		$1.11M Buy
4,386
+1,318
+43% +$385K 0.12% 206
2021
Q3 		$1.18M Buy
3,068
+1,790
+140% +$660K 0.18% 122
2021
Q2 		$300K Buy
+1,278
New +$228K 0.06% 381
2020
Q3 		– Sell
-3,355
Closed -$215K – 914
2020
Q2 		$215K Buy
+3,355
New +$184K ﹤0.01% 813

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Simplicity Solutions's MRNA Position: Q4 2023 in Review

Simplicity Solutions reduced its Moderna (MRNA) stake by 24% in Q4 2023, selling an estimated $89.3K and leaving 3,349 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #801.

Simplicity Solutions first reported a position in MRNA in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.24M in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Simplicity Solutions held 3,349 shares of Moderna worth $333K as of Q4 2023.
  • Simplicity Solutions sold 1,062 Moderna shares in Q4 2023, an estimated $89.3K.
  • Moderna made up 0.01% of Simplicity Solutions's portfolio in Q4 2023, its #801 holding.
  • Simplicity Solutions first reported a position in Moderna in Q2 2020 and has held it in 12 quarters since.
  • Simplicity Solutions's Moderna position peaked at $1.24M in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.